Erectile dysfunction: interrelationship with the metabolic syndrome
- PMID: 15663920
- DOI: 10.1007/s11892-005-0070-8
Erectile dysfunction: interrelationship with the metabolic syndrome
Abstract
Erectile dysfunction (ED) is more commonly seen in men with various components of the metabolic syndrome (a constellation of various cardiovascular and diabetes risk factors). ED can be considered as a risk marker of the metabolic syndrome and its associated conditions. The patient with ED should be thoroughly evaluated for coexisting vascular disease. Any cardiovascular risk factors should be modified or treated (ie, smoking, diabetes, hypertension, and hyperlipidemia). Endothelial dysfunction is a major unifying etiology for many of the aspects of the metabolic syndrome, especially diabetes and cardiovascular disease. It also plays a major role in ED. The multifactorial etiology of ED, especially in patients with the metabolic syndrome, increases the complexity of managing this problem so clinicians need to be aware of the underlying pathophysiology to ensure the best possible outcomes in management.
Similar articles
-
Erectile dysfunction in diabetic patients.J Med Liban. 2004 Oct-Dec;52(4):217-9. J Med Liban. 2004. PMID: 16432985 Review.
-
Erectile dysfunction and dyslipidemia: relevance and role of phosphodiesterase type-5 inhibitors and statins.J Sex Med. 2008 May;5(5):1066-1078. doi: 10.1111/j.1743-6109.2008.00783.x. Epub 2008 Mar 5. J Sex Med. 2008. PMID: 18331271 Review.
-
Endothelial and erectile dysfunction, diabetes mellitus, and the metabolic syndrome: common pathways and treatments?Am J Cardiol. 2005 Dec 26;96(12B):13M-18M. doi: 10.1016/j.amjcard.2005.07.005. Epub 2005 Dec 1. Am J Cardiol. 2005. PMID: 16387560 Review.
-
Management of erectile dysfunction in diabetes: an update for 2008.Curr Diab Rep. 2008 Dec;8(6):437-43. doi: 10.1007/s11892-008-0076-0. Curr Diab Rep. 2008. PMID: 18990299 Review.
-
The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment.Diabet Med. 2006 Aug;23(8):873-8. doi: 10.1111/j.1464-5491.2006.01911.x. Diabet Med. 2006. PMID: 16911625
Cited by
-
Markers of erectile dysfunction.Indian J Urol. 2008 Jul;24(3):320-8. doi: 10.4103/0970-1591.42612. Indian J Urol. 2008. PMID: 19468461 Free PMC article.
-
Identification of miRNA Signature Associated With Erectile Dysfunction in Type 2 Diabetes Mellitus by Support Vector Machine-Recursive Feature Elimination.Front Genet. 2021 Oct 11;12:762136. doi: 10.3389/fgene.2021.762136. eCollection 2021. Front Genet. 2021. PMID: 34707644 Free PMC article.
-
The impact of poor glycaemic control on the prevalence of erectile dysfunction in men with type 2 diabetes mellitus: a systematic review.JRSM Open. 2016 Feb 12;7(3):2054270415622602. doi: 10.1177/2054270415622602. eCollection 2016 Mar. JRSM Open. 2016. PMID: 26981254 Free PMC article.
-
Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.J Sex Med. 2009 Mar;6 Suppl 3(Suppl 3):269-78. doi: 10.1111/j.1743-6109.2008.01184.x. J Sex Med. 2009. PMID: 19267849 Free PMC article.
-
[Metabolic syndrome and erectile dysfunction. Epidemiologic associations and pathogenetic links].Urologe A. 2007 Mar;46(3):287-92. doi: 10.1007/s00120-006-1244-y. Urologe A. 2007. PMID: 17160668 Review. German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical